12
Participants
Start Date
October 16, 2017
Primary Completion Date
March 30, 2018
Study Completion Date
March 30, 2018
LAMELLEYE
Liposomal multi-dose preservative-free sterile suspension which contains soy lecithin phospholipids, sphingomyelin and cholesterol, suspended in saline.
OPTIVE FUSION
Multi-dose sterile solution which contains sodium hyaluronate 0.1%, sodium carboxymethylcellulose 0.5%, glycerine 0.9%, erythritol, boric acid, sodium citrate dihydrate, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, and is preserved with PURITE® 0.01% which breaks down into natural tear components on the eye.
Collaborators (1)
Lamellar Biomedical Ltd
INDUSTRY
Robertson Centre for Biostatistics - University of Glasgow
UNKNOWN
Glasgow Caledonian University
OTHER
NHS Greater Glasgow and Clyde
OTHER